speb/financial-data huggingface dataset:
IVX.V income_statement (annual, 2024-12-31) — Diluted Average Shares: 4871145.00
IVX.V income_statement (annual, 2024-12-31) — Diluted EPS: -0.01
IVX.V income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -62000.00
IVX.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -242000.00
IVX.V income_statement (annual, 2024-12-31) — EBIT: 44000.00
IVX.V income_statement (quarterly, 2024-12-31) — EBIT: -286000.00
IVX.V income_statement (annual, 2024-12-31) — EBITDA: 247000.00
IVX.V income_statement (quarterly, 2024-12-31) — EBITDA: -235000.00
IVX.V cash_flow (annual, 2024-12-31) — End Cash Position: 836000.00
IVX.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 836000.00
IVX.V cash_flow (annual, 2024-12-31) — Financing Cash Flow: -808000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -84000.00
IVX.V balance_sheet (annual, 2024-12-31) — Finished Goods: 150000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Finished Goods: 150000.00
IVX.V cash_flow (annual, 2024-12-31) — Free Cash Flow: 711000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: 32000.00
IVX.V balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 536000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 536000.00
IVX.V balance_sheet (annual, 2024-12-31) — Gross PPE: 11213000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 11213000.00
IVX.V income_statement (annual, 2024-12-31) — Gross Profit: 953000.00
IVX.V income_statement (quarterly, 2024-12-31) — Gross Profit: 135000.00
IVX.V balance_sheet (annual, 2024-12-31) — Income Tax Payable: 0.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Income Tax Payable: 0.00
IVX.V income_statement (annual, 2024-12-31) — Interest Expense: 146000.00
IVX.V income_statement (quarterly, 2024-12-31) — Interest Expense: 62000.00
IVX.V income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 146000.00
IVX.V income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 62000.00
IVX.V cash_flow (annual, 2024-12-31) — Interest Paid Cff: -146000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Interest Paid Cff: -39000.00
IVX.V balance_sheet (annual, 2024-12-31) — Inventory: 966000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Inventory: 966000.00
IVX.V balance_sheet (annual, 2024-12-31) — Invested Capital: 4517000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: 4517000.00
IVX.V cash_flow (annual, 2024-12-31) — Investing Cash Flow: -213000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -27000.00
IVX.V cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 0.00
IVX.V cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
IVX.V cash_flow (annual, 2024-12-31) — Issuance Of Debt: 0.00
IVX.V cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
IVX.V balance_sheet (annual, 2024-12-31) — Land And Improvements: 6000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 6000.00
IVX.V balance_sheet (annual, 2024-12-31) — Long Term Debt: 2250000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 2250000.00
IVX.V balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2250000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 2250000.00
IVX.V cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 0.00
IVX.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
IVX.V cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -175000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -45000.00
IVX.V balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 8791000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 8791000.00
IVX.V cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 0.00
IVX.V cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
IVX.V balance_sheet (annual, 2024-12-31) — Net Debt: 1414000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Net Debt: 1414000.00
IVX.V income_statement (annual, 2024-12-31) — Net Income: -62000.00
IVX.V income_statement (quarterly, 2024-12-31) — Net Income: -242000.00
IVX.V income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -62000.00
IVX.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -242000.00
IVX.V income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -62000.00
IVX.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -242000.00
IVX.V income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -62000.00
IVX.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -242000.00
IVX.V income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -62000.00
IVX.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -242000.00
IVX.V cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -62000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -242000.00
IVX.V income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -62000.00
IVX.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -242000.00
IVX.V income_statement (annual, 2024-12-31) — Net Interest Income: -146000.00
IVX.V income_statement (quarterly, 2024-12-31) — Net Interest Income: -62000.00
IVX.V cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -175000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -45000.00
IVX.V cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -175000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -45000.00
IVX.V income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -146000.00
IVX.V income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -62000.00
IVX.V balance_sheet (annual, 2024-12-31) — Net PPE: 3244000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Net PPE: 3244000.00
IVX.V cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -213000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Net PPE Purchase And Sale: -27000.00
IVX.V balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 2267000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Net Tangible Assets: 2267000.00
IVX.V balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 263000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Liabilities: 263000.00
IVX.V balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 263000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Taxes Liabilities: 263000.00
IVX.V income_statement (annual, 2024-12-31) — Normalized EBITDA: 247000.00
IVX.V income_statement (quarterly, 2024-12-31) — Normalized EBITDA: -235000.00
IVX.V income_statement (annual, 2024-12-31) — Normalized Income: -62000.00
IVX.V income_statement (quarterly, 2024-12-31) — Normalized Income: -242000.00
IVX.V cash_flow (annual, 2024-12-31) — Operating Cash Flow: 924000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Operating Cash Flow: 59000.00
IVX.V income_statement (annual, 2024-12-31) — Operating Income: 44000.00
IVX.V income_statement (quarterly, 2024-12-31) — Operating Income: -286000.00
IVX.V income_statement (annual, 2024-12-31) — Operating Revenue: 6309000.00
IVX.V income_statement (quarterly, 2024-12-31) — Operating Revenue: 1328000.00
IVX.V balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 4871145.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 4871145.00
IVX.V balance_sheet (annual, 2024-12-31) — Other Current Assets: 31000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Other Current Assets: 31000.00
IVX.V balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Other Current Liabilities: 1000.00
IVX.V cash_flow (annual, 2024-12-31) — Other Non Cash Items: 146000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Other Non Cash Items: 40000.00
IVX.V balance_sheet (annual, 2024-12-31) — Other Payable: 3000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Other Payable: 3000.00
IVX.V balance_sheet (annual, 2024-12-31) — Payables: 465000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Payables: 465000.00
IVX.V balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 747000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Payables And Accrued Expenses: 747000.00
IVX.V income_statement (annual, 2024-12-31) — Pretax Income: -102000.00
IVX.V income_statement (quarterly, 2024-12-31) — Pretax Income: -348000.00
IVX.V cash_flow (annual, 2024-12-31) — Purchase Of PPE: -213000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Purchase Of PPE: -27000.00
IVX.V balance_sheet (annual, 2024-12-31) — Raw Materials: 800000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Raw Materials: 800000.00
IVX.V balance_sheet (annual, 2024-12-31) — Receivables: 636000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Receivables: 636000.00
IVX.V income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 5356000.00
IVX.V income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 1193000.00
IVX.V income_statement (annual, 2024-12-31) — Reconciled Depreciation: 203000.00
IVX.V income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 51000.00
IVX.V cash_flow (annual, 2024-12-31) — Repayment Of Debt: -175000.00
IVX.V cash_flow (quarterly, 2024-12-31) — Repayment Of Debt: -45000.00
IVX.V balance_sheet (annual, 2024-12-31) — Retained Earnings: 564000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Retained Earnings: 564000.00
IVX.V income_statement (annual, 2024-12-31) — Selling General And Administration: 909000.00
IVX.V income_statement (quarterly, 2024-12-31) — Selling General And Administration: 421000.00
IVX.V balance_sheet (annual, 2024-12-31) — Share Issued: 4871145.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Share Issued: 4871145.00
IVX.V cash_flow (annual, 2024-12-31) — Stock Based Compensation: 2000.00
IVX.V balance_sheet (annual, 2024-12-31) — Stockholders Equity: 2267000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 2267000.00
IVX.V balance_sheet (annual, 2024-12-31) — Tangible Book Value: 2267000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 2267000.00
IVX.V income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IVX.V income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
IVX.V income_statement (annual, 2024-12-31) — Tax Provision: -40000.00
IVX.V income_statement (quarterly, 2024-12-31) — Tax Provision: -106000.00
IVX.V income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.39
IVX.V income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.30
IVX.V balance_sheet (annual, 2024-12-31) — Taxes Receivable: 100000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Taxes Receivable: 100000.00
IVX.V balance_sheet (annual, 2024-12-31) — Total Assets: 5713000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Total Assets: 5713000.00
IVX.V balance_sheet (annual, 2024-12-31) — Total Capitalization: 4517000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 4517000.00
IVX.V balance_sheet (annual, 2024-12-31) — Total Debt: 2436000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Total Debt: 2436000.00
IVX.V balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 2267000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 2267000.00
IVX.V income_statement (annual, 2024-12-31) — Total Expenses: 6265000.00
IVX.V income_statement (quarterly, 2024-12-31) — Total Expenses: 1614000.00
IVX.V balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 3446000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 3446000.00
IVX.V balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 3244000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Assets: 3244000.00
IVX.V balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2513000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 2513000.00
IVX.V balance_sheet (annual, 2024-12-31) — Total Tax Payable: 0.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Total Tax Payable: 0.00
IVX.V balance_sheet (annual, 2024-12-31) — Work In Process: 16000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Work In Process: 16000.00
IVX.V balance_sheet (annual, 2024-12-31) — Working Capital: 1536000.00
IVX.V balance_sheet (quarterly, 2024-12-31) — Working Capital: 1536000.00
IVX.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 265000.00
IVX.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 2427000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 765000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1413000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 366000.00
IVX.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 4871145.00
IVX.V income_statement (quarterly, 2025-03-31) — Basic EPS: 0.04
IVX.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 836000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -19000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1337000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 454000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 454000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Cash Financial: 454000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -80000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -19000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -283000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Change In Account Payable: 391000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Change In Inventory: -33000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -13000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Change In Payable: 391000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 391000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: -877000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -532000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -877000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: -382000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 1337000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 2450000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
IVX.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1884000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 281000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 2937000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 190000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1255000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Depreciation: 44000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 44000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 44000.00
IVX.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 4871145.00
IVX.V income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.04
IVX.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 183000.00
IVX.V income_statement (quarterly, 2025-03-31) — EBIT: 278000.00
IVX.V income_statement (quarterly, 2025-03-31) — EBITDA: 322000.00
IVX.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 454000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -80000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Finished Goods: 74000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -302000.00
IVX.V income_statement (quarterly, 2025-03-31) — Gross Profit: 543000.00
IVX.V income_statement (quarterly, 2025-03-31) — Interest Expense: 35000.00
IVX.V income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 35000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -35000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Inventory: 999000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 4651000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -19000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 2201000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2201000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -45000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Net Debt: 1747000.00
IVX.V income_statement (quarterly, 2025-03-31) — Net Income: 183000.00
IVX.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 183000.00
IVX.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 183000.00
IVX.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 183000.00
IVX.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 183000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 183000.00
IVX.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 183000.00
IVX.V income_statement (quarterly, 2025-03-31) — Net Interest Income: -35000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -45000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -45000.00
IVX.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -35000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 3218000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -19000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 2450000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 250000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 250000.00
IVX.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 322000.00
IVX.V income_statement (quarterly, 2025-03-31) — Normalized Income: 183000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -283000.00
IVX.V income_statement (quarterly, 2025-03-31) — Operating Income: 278000.00
IVX.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 2427000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 4871145.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 44000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 22000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -1000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Other Payable: 19000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Payables: 784000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1065000.00
IVX.V income_statement (quarterly, 2025-03-31) — Pretax Income: 243000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -19000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Raw Materials: 816000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Receivables: 1440000.00
IVX.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1884000.00
IVX.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 44000.00
IVX.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -45000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 747000.00
IVX.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 265000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 4871145.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 2450000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2450000.00
IVX.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
IVX.V income_statement (quarterly, 2025-03-31) — Tax Provision: 60000.00
IVX.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.25
IVX.V balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 27000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 6155000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 4651000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 2391000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 2450000.00
IVX.V income_statement (quarterly, 2025-03-31) — Total Expenses: 2149000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 3705000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 3218000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 2450000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Work In Process: 109000.00
IVX.V balance_sheet (quarterly, 2025-03-31) — Working Capital: 1682000.00
IVX.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 234000.00
IVX.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 2190000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 597000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 1257000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 370000.00
IVX.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 4871145.00
IVX.V income_statement (quarterly, 2025-06-30) — Basic EPS: 0.03
IVX.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 454000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -5000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1337000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 654000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 654000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: 0.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Cash Financial: 654000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -80000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -5000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 286000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Change In Inventory: 24000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -27000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 132000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Change In Payable: -221000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: -221000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: 156000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 64000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: 200000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 1337000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: 0.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 2592000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
IVX.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1734000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 223000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 2957000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 193000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1142000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Depreciation: 45000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 45000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 45000.00
IVX.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 4871145.00
IVX.V income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.03
IVX.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 138000.00
IVX.V income_statement (quarterly, 2025-06-30) — EBIT: 222000.00
IVX.V income_statement (quarterly, 2025-06-30) — EBITDA: 267000.00
IVX.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 654000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -80000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Finished Goods: 201000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 280000.00
IVX.V income_statement (quarterly, 2025-06-30) — Gross Profit: 456000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Income Tax Payable: 105000.00
IVX.V income_statement (quarterly, 2025-06-30) — Interest Expense: 34000.00
IVX.V income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 34000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Interest Paid Cff: -34000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Inventory: 975000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 4743000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -5000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 2151000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2151000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -46000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Net Debt: 1497000.00
IVX.V income_statement (quarterly, 2025-06-30) — Net Income: 138000.00
IVX.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 138000.00
IVX.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 138000.00
IVX.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 138000.00
IVX.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 138000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 138000.00
IVX.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 138000.00
IVX.V income_statement (quarterly, 2025-06-30) — Net Interest Income: -34000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -46000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -46000.00
IVX.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -34000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 3178000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -5000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 2592000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 250000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 250000.00
IVX.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 267000.00
IVX.V income_statement (quarterly, 2025-06-30) — Normalized Income: 138000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 285000.00
IVX.V income_statement (quarterly, 2025-06-30) — Operating Income: 222000.00
IVX.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 2190000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 4871145.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 71000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 38000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Other Payable: 24000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Payables: 726000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 949000.00
IVX.V income_statement (quarterly, 2025-06-30) — Pretax Income: 188000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -5000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Raw Materials: 718000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Receivables: 1257000.00
IVX.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1734000.00
IVX.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 45000.00
IVX.V cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -46000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 885000.00
IVX.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 234000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 4871145.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 2592000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 2592000.00
IVX.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
IVX.V income_statement (quarterly, 2025-06-30) — Tax Provision: 50000.00
IVX.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.27
IVX.V balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 0.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 6135000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 4743000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 2344000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 2592000.00
IVX.V income_statement (quarterly, 2025-06-30) — Total Expenses: 1968000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 3543000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 3178000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2401000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 105000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Work In Process: 56000.00
IVX.V balance_sheet (quarterly, 2025-06-30) — Working Capital: 1815000.00
IVX.V income_statement (annual, 2025-12-31) — +Operating Expense: 942000.00
IVX.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 231000.00
IVX.V income_statement (annual, 2025-12-31) — +Total Revenue: 8247000.00
IVX.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 1552000.00
IVX.V balance_sheet (annual, 2025-12-31) — Accounts Payable: 341000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 341000.00
IVX.V balance_sheet (annual, 2025-12-31) — Accounts Receivable: 612000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 612000.00
IVX.V balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7869000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7869000.00
IVX.V balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 398000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 398000.00
IVX.V balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -78000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -78000.00
IVX.V income_statement (annual, 2025-12-31) — Basic Average Shares: 4871145.00
IVX.V income_statement (annual, 2025-12-31) — Basic EPS: 0.06
IVX.V cash_flow (annual, 2025-12-31) — Beginning Cash Position: 836000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1132000.00
IVX.V balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 2412000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 2412000.00
IVX.V cash_flow (annual, 2025-12-31) — Capital Expenditure: -85000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -48000.00
IVX.V balance_sheet (annual, 2025-12-31) — Capital Stock: 1337000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1337000.00
IVX.V balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 990000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 990000.00
IVX.V balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 990000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 990000.00
IVX.V cash_flow (annual, 2025-12-31) — Cash Dividends Paid: 0.00
IVX.V cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: 0.00
IVX.V balance_sheet (annual, 2025-12-31) — Cash Financial: 990000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Cash Financial: 990000.00
IVX.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -320000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -80000.00
IVX.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -85000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -48000.00
IVX.V cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 559000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -14000.00
IVX.V cash_flow (annual, 2025-12-31) — Change In Inventory: 75000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Change In Inventory: 6000.00
IVX.V cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -15000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 26000.00
IVX.V cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 175000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -71000.00
IVX.V cash_flow (annual, 2025-12-31) — Change In Payable: -244000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Change In Payable: -318000.00
IVX.V cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -244000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -318000.00
IVX.V cash_flow (annual, 2025-12-31) — Change In Receivables: -76000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: 373000.00
IVX.V cash_flow (annual, 2025-12-31) — Change In Working Capital: -85000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 16000.00
IVX.V cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -76000.00
IVX.V cash_flow (annual, 2025-12-31) — Changes In Cash: 154000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: -142000.00
IVX.V balance_sheet (annual, 2025-12-31) — Common Stock: 1337000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 1337000.00
IVX.V cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: 0.00
IVX.V cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: 0.00
IVX.V balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2581000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2581000.00
IVX.V income_statement (annual, 2025-12-31) — Cost Of Revenue: 6774000.00
IVX.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1476000.00
IVX.V balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 153000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 153000.00
IVX.V balance_sheet (annual, 2025-12-31) — Current Assets: 2539000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 2539000.00
IVX.V balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 200000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 200000.00
IVX.V balance_sheet (annual, 2025-12-31) — Current Liabilities: 778000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 778000.00
IVX.V cash_flow (annual, 2025-12-31) — Deferred Income Tax: 16000.00
IVX.V cash_flow (annual, 2025-12-31) — Deferred Tax: 16000.00
IVX.V cash_flow (annual, 2025-12-31) — Depreciation: 180000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Depreciation: 45000.00
IVX.V cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 180000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 45000.00
IVX.V cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 180000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 45000.00
IVX.V income_statement (annual, 2025-12-31) — Diluted Average Shares: 4955127.00
IVX.V income_statement (annual, 2025-12-31) — Diluted EPS: 0.06
IVX.V income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 282000.00
IVX.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -151000.00
IVX.V income_statement (annual, 2025-12-31) — EBIT: 531000.00
IVX.V income_statement (quarterly, 2025-12-31) — EBIT: -155000.00
IVX.V income_statement (annual, 2025-12-31) — EBITDA: 711000.00
IVX.V income_statement (quarterly, 2025-12-31) — EBITDA: -110000.00
IVX.V cash_flow (annual, 2025-12-31) — End Cash Position: 990000.00
IVX.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 990000.00
IVX.V cash_flow (annual, 2025-12-31) — Financing Cash Flow: -320000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -80000.00
IVX.V balance_sheet (annual, 2025-12-31) — Finished Goods: 123000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Finished Goods: 123000.00
IVX.V cash_flow (annual, 2025-12-31) — Free Cash Flow: 474000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -62000.00
IVX.V balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 690000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 690000.00
IVX.V balance_sheet (annual, 2025-12-31) — Gross PPE: 11018000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 11018000.00
IVX.V income_statement (annual, 2025-12-31) — Gross Profit: 1473000.00
IVX.V income_statement (quarterly, 2025-12-31) — Gross Profit: 76000.00
IVX.V balance_sheet (annual, 2025-12-31) — Income Tax Payable: 75000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 75000.00
IVX.V income_statement (annual, 2025-12-31) — Interest Expense: 134000.00
IVX.V income_statement (quarterly, 2025-12-31) — Interest Expense: 32000.00
IVX.V income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 134000.00
IVX.V income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 32000.00
IVX.V cash_flow (annual, 2025-12-31) — Interest Paid Cff: -134000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Interest Paid Cff: -33000.00
IVX.V balance_sheet (annual, 2025-12-31) — Inventory: 891000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Inventory: 891000.00
IVX.V balance_sheet (annual, 2025-12-31) — Invested Capital: 4631000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Invested Capital: 4631000.00
IVX.V cash_flow (annual, 2025-12-31) — Investing Cash Flow: -85000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -48000.00
IVX.V balance_sheet (annual, 2025-12-31) — Land And Improvements: 6000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 6000.00
IVX.V balance_sheet (annual, 2025-12-31) — Long Term Debt: 2050000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 2050000.00
IVX.V balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2050000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 2050000.00
IVX.V cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -186000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -47000.00
IVX.V balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 8600000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 8600000.00
IVX.V balance_sheet (annual, 2025-12-31) — Net Debt: 1060000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Net Debt: 1060000.00
IVX.V income_statement (annual, 2025-12-31) — Net Income: 282000.00
IVX.V income_statement (quarterly, 2025-12-31) — Net Income: -151000.00
IVX.V income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 282000.00
IVX.V income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -151000.00
IVX.V income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 282000.00
IVX.V income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -151000.00
IVX.V income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 282000.00
IVX.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -151000.00
IVX.V income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 282000.00
IVX.V income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -151000.00
IVX.V cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 282000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -151000.00
IVX.V income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 282000.00
IVX.V income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -151000.00
IVX.V income_statement (annual, 2025-12-31) — Net Interest Income: -134000.00
IVX.V income_statement (quarterly, 2025-12-31) — Net Interest Income: -32000.00
IVX.V cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -186000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -47000.00
IVX.V cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -186000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -47000.00
IVX.V income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -134000.00
IVX.V income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -32000.00
IVX.V balance_sheet (annual, 2025-12-31) — Net PPE: 3149000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Net PPE: 3149000.00
IVX.V cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -85000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -48000.00
IVX.V balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2581000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2581000.00
IVX.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 279000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 279000.00
IVX.V balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 279000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 279000.00
IVX.V income_statement (annual, 2025-12-31) — Normalized EBITDA: 711000.00
IVX.V income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -110000.00
IVX.V income_statement (annual, 2025-12-31) — Normalized Income: 282000.00
IVX.V income_statement (quarterly, 2025-12-31) — Normalized Income: -151000.00
IVX.V cash_flow (annual, 2025-12-31) — Operating Cash Flow: 559000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -14000.00
IVX.V income_statement (annual, 2025-12-31) — Operating Income: 531000.00
IVX.V income_statement (quarterly, 2025-12-31) — Operating Income: -155000.00
IVX.V income_statement (annual, 2025-12-31) — Operating Revenue: 8247000.00
IVX.V income_statement (quarterly, 2025-12-31) — Operating Revenue: 1552000.00
IVX.V balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 4871145.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 4871145.00
IVX.V balance_sheet (annual, 2025-12-31) — Other Current Assets: 46000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 46000.00
IVX.V cash_flow (annual, 2025-12-31) — Other Non Cash Items: 134000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 28000.00
IVX.V balance_sheet (annual, 2025-12-31) — Other Payable: 9000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Other Payable: 9000.00
IVX.V balance_sheet (annual, 2025-12-31) — Payables: 425000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Payables: 425000.00
IVX.V balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 578000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 578000.00
IVX.V income_statement (annual, 2025-12-31) — Pretax Income: 397000.00
IVX.V income_statement (quarterly, 2025-12-31) — Pretax Income: -187000.00
IVX.V cash_flow (annual, 2025-12-31) — Purchase Of PPE: -85000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -48000.00
IVX.V balance_sheet (annual, 2025-12-31) — Raw Materials: 761000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Raw Materials: 761000.00
IVX.V balance_sheet (annual, 2025-12-31) — Receivables: 612000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Receivables: 612000.00
IVX.V income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 6774000.00
IVX.V income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1476000.00
IVX.V income_statement (annual, 2025-12-31) — Reconciled Depreciation: 180000.00
IVX.V income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 45000.00
IVX.V cash_flow (annual, 2025-12-31) — Repayment Of Debt: -186000.00
IVX.V cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -47000.00
IVX.V balance_sheet (annual, 2025-12-31) — Retained Earnings: 846000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 846000.00
IVX.V income_statement (annual, 2025-12-31) — Selling General And Administration: 942000.00
IVX.V income_statement (quarterly, 2025-12-31) — Selling General And Administration: 231000.00
IVX.V balance_sheet (annual, 2025-12-31) — Share Issued: 4871145.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Share Issued: 4871145.00
IVX.V cash_flow (annual, 2025-12-31) — Stock Based Compensation: 32000.00
IVX.V balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2581000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2581000.00
IVX.V balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2581000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2581000.00
IVX.V income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IVX.V income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IVX.V income_statement (annual, 2025-12-31) — Tax Provision: 115000.00
IVX.V income_statement (quarterly, 2025-12-31) — Tax Provision: -36000.00
IVX.V income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.29
IVX.V income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.19
IVX.V balance_sheet (annual, 2025-12-31) — Taxes Receivable: 0.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 0.00
IVX.V balance_sheet (annual, 2025-12-31) — Total Assets: 5688000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Total Assets: 5688000.00
IVX.V balance_sheet (annual, 2025-12-31) — Total Capitalization: 4631000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 4631000.00
IVX.V balance_sheet (annual, 2025-12-31) — Total Debt: 2250000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Total Debt: 2250000.00
IVX.V balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2581000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2581000.00
IVX.V income_statement (annual, 2025-12-31) — Total Expenses: 7716000.00
IVX.V income_statement (quarterly, 2025-12-31) — Total Expenses: 1707000.00
IVX.V balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3107000.00
IVX.V balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3107000.00
IVX.V balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3149000.00